Orchestra BioMed

Orchestra BioMed is a U.S.-based developer of cardiovascular disease drugs, primarily focusing on unmet needs in cardiovascular diseases. Its core innovation and product development expertise lie in the fields of drug delivery, interventional devices, bioelectronics, and neuromodulation. Candidate products include the Virtue Sirolimus-Eluting Balloon for treating arterial diseases and the BackBeat Cardiac Neuromodulation Therapy for treating hypertension.